| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACO1
|
aconitase 1, soluble
|
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2
|
|
ACTB
|
actin, beta
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOE
|
apolipoprotein E
|
|
ARRB1
|
arrestin, beta 1
|
|
ATF1
|
activating transcription factor 1
|
|
ATG14
|
autophagy related 14
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP4B
|
ATPase, H+/K+ exchanging, beta polypeptide
|
|
AXIN2
|
axin 2
|
|
B2M
|
beta-2-microglobulin
|
|
BECN1
|
beclin 1, autophagy related
|
|
BID
|
BH3 interacting domain death agonist
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCNB1
|
cyclin B1
|
|
CD28
|
CD28 molecule
|
|
CD34
|
CD34 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDC20
|
cell division cycle 20
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX4I2
|
cytochrome c oxidase subunit IV isoform 2 (lung)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3
|
cAMP responsive element binding protein 3
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYTH1
|
cytohesin 1
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DDT
|
D-dopachrome tautomerase
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DNM1
|
dynamin 1
|
|
DNM3
|
dynamin 3
|
|
DRD4
|
dopamine receptor D4
|
|
EFNA1
|
ephrin-A1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
ELN
|
elastin
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
FAS
|
Fas cell surface death receptor
|
|
FBN2
|
fibrillin 2
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FOXP3
|
forkhead box P3
|
|
FXN
|
frataxin
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GUCA1A
|
guanylate cyclase activator 1A (retina)
|
|
HCFC1
|
host cell factor C1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIST1H1B
|
histone cluster 1, H1b
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KDR
|
kinase insert domain receptor
|
|
KIF4A
|
kinesin family member 4A
|
|
LAP3
|
leucine aminopeptidase 3
|
|
LEP
|
leptin
|
|
LILRA2
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
|
|
MAOB
|
monoamine oxidase B
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPB
|
natriuretic peptide B
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPY
|
neuropeptide Y
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLN
|
phospholamban
|
|
PON1
|
paraoxonase 1
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROM1
|
prominin 1
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RET
|
ret proto-oncogene
|
|
RPS6KA4
|
ribosomal protein S6 kinase, 90kDa, polypeptide 4
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEPT7
|
septin 7
|
|
SEPW1
|
selenoprotein W, 1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGK3
|
serum/glucocorticoid regulated kinase family, member 3
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SLC1A6
|
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6
|
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SP1
|
Sp1 transcription factor
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK25
|
serine/threonine kinase 25
|
|
TFF1
|
trefoil factor 1
|
|
THBS1
|
thrombospondin 1
|
|
THPO
|
thrombopoietin
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TIGAR
|
TP53 induced glycolysis regulatory phosphatase
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TP53
|
tumor protein p53
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
XYLT1
|
xylosyltransferase I
|
|
ZC3HAV1
|
zinc finger CCCH-type, antiviral 1
|
